Clinical chemistry is an exciting field that combines analytics and instrumentation with information technology and management of workflow, staff efficiencies and high-volume automation. Chemistry analyzers can be benchtop devices or other systems which require floor space. They are used to determine the concentration of certain metabolites, electrolytes, proteins, and/or drugs in samples of serum, plasma, urine, cerebrospinal fluid, and/or other body fluids. Analytes commonly include enzymes, substrates, electrolytes, specific proteins, drugs of abuse, and therapeutic drugs. Analyzer, reagents and consumables form a reliable, fully supported system solution offering to the laboratory ease of use and time saving automation that supports routine daily work.
Ongoing developments in analytical laboratory automation, the swift progress in various fields of diagnosis and, the geographical market expansion within emerging countries are propelling the escalating demand for benchtop clinical chemistry analysers industry. Furthermore, surging use of automation and robotics coupled with integration of software coupled with increasing demand for modular automation is also one of the factor which is fueling the benchtop clinical chemistry analyzers market growth globally. However, requirement of high capital investments is one of the major factor hindering the growth of benchtop clinical chemistry analyzers market globally.
The global benchtop clinical chemistry analyzer market has been portioned into North America, Europe, Asia Pacific and Rest of the World. The North American region dominated the global benchtop clinical chemistry analyzer market in 2019. Advanced healthcare infrastructure and high disposable income in this region is expected to majorly drive the benchtop clinical chemistry analyzer market during the forecast period. Likewise, Asia-Pacific region is predicted to be the fastest growing region in the global benchtop clinical chemistry analyzer market. Rapidly growing demand for better healthcare and government policies which are focusing on the healthcare sector is propelling the demand of benchtop clinical chemistry analyzer in Asia-Pacific region.
• Among various products in the report, the substantial share is predicted to be a consequence of wide array of reagents present in the market, catering to different requirements. In addition, reagents are believed to be highly cost efficient, possess optimum sensitivity, linearity, and precision, which thereby, ensures minimized performance variation.
• Fully automated benchtop clinical chemistry analyzer segment dominated the market owing to various properties such as intelligent multitasking software, perfect self-checking function, automatic calibration, automatic washing, maximum throughput, with onboard cooling and advanced technology.
• Basic Metabolic Panel (BMP) accounted for the largest market share in 2019. Rising importance of and awareness regarding point-of-care testing is also one of the key contributing factors toward the segment share.
• The growth of commercial laboratories segment is attributed by various drives such as several major technological advances, scientific achievement combined with growing prevalence of various lifestyle disease diagnosis in clinical laboratories. Furthermore, supportive infrastructure facilitates and successful diagnostic procedures, thus, resulting in the growth of hospitals segment.
The major companies operating in the benchtop clinical chemistry analyzer market include AGD Biomedicals Pvt. Ltd., AMS Alliance, Balio Diagnostics, Beckman Coulter (Subsidiary of Danaher Corporation), Biochemical Systems International S.p.A., DiaSys Diagnostic Systems GmbH, EKF Diagnostics, Elitech Group, F. Hoffmann-La Roche Ltd., Horiba, Ltd., Medica Corporation, Meril Life Sciences Pvt. Ltd., Mindray Medical International Limited, Randox Laboratories Ltd., Siemens AG, Thermo Fisher Scientific Inc., and Wiener lab Group. New product launch and expansion are the key growth strategies adopted by these leading players to enhance their product offering and regional presence and meet the growing demand for benchtop clinical chemistry analyzerss from the emerging economies.
The report analyses the global benchtop clinical chemistry analyzer market based on product, type, test, end user and geography. Various products studied in the global benchtop clinical chemistry analyzer market are analyzers, reagents & consumables and other products (software and services). The benchtop clinical chemistry analyzer is manufactured by two types such as fully automated and semi-automated. The tests studied in the global benchtop clinical chemistry analyzer are basic metabolic panel, electrolyte panels, liver panel, lipid profile, renal profiles, thyroid function panel and specialty chemicals. The major end user of the market are hospitals, commercial laboratories, academic institutes and others.
The North American region dominated the global benchtop clinical chemistry analyzer market in 2019. Advanced healthcare infrastructure and high disposable income in this region is expected to majorly drive the benchtop clinical chemistry analyzer market during the forecast period. Likewise, Asia-Pacific region is predicted to be the fastest growing region in the global benchtop clinical chemistry analyzer market.
Why to buy this report: